Toll‐like receptor 4 signaling in hematopoietic‐lineage cells contributes to the enhanced activity of the human vaccine adjuvant AS01

Van Maele, Laurye; Fougeron, Delphine; Cayet, Delphine; Chalon, Aurélie; Piccioli, Diego; Collignon, Catherine; Sirard, Jean‐Claude; Didierlaurent, Arnaud

doi:10.1002/eji.201948234

Scientific article

English

Toll‐like receptor 4 signaling in hematopoietic‐lineage cells contributes to the enhanced activity of the human vaccine adjuvant AS01

ContributorsVan Maele, Laurye; Fougeron, Delphine; Cayet, Delphine; Chalon, Aurélie; Piccioli, Diego; Collignon, Catherine; Sirard, Jean‐Claude; Didierlaurent, Arnaud

Published inEuropean Journal of Immunology, vol. 49, no. 12, p. 2134-2145

Publication date2019

Affiliation entities

Not a UNIGE publication

Research groups

Laboratoire d'immunologie vaccinale humaine (1025)

Citation (ISO format)

VAN MAELE, Laurye et al. Toll‐like receptor 4 signaling in hematopoietic‐lineage cells contributes to the enhanced activity of the human vaccine adjuvant AS01. In: European Journal of Immunology, 2019, vol. 49, n° 12, p. 2134–2145. doi: 10.1002/eji.201948234

Article (Published version)

CC BY

Identifiers

PID : unige:143064
DOI : 10.1002/eji.201948234
PMID : 31489613

Additional URL for this publicationhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.201948234

Journal ISSN0014-2980

299views

223downloads

Creation12/10/2020 14:29:00

First validation12/10/2020 14:29:00

Update15/03/2023 22:46:03

Status update15/03/2023 22:46:02

Last indexation31/10/2024 19:57:14

Archive ouverte UNIGE

Toll‐like receptor 4 signaling in hematopoietic‐lineage cells contributes to the enhanced activity of the human vaccine adjuvant AS01

Technical informations